Vnitr Lek 2011, 57(12):1038-1044

Survival of patients after TIPS in the University Hospital Hradec Kralove

Š. Šembera1,*, V. Jirkovský2, T. Fejfar2, V. Šafka2, O. Renc3, J. Raupach3, V. Chovanec3, M. Lojík3, A. Krajina3, P. Hůlek2
1 Lékařská fakulta UK Hradec Králové, děkan prof. MUDr. RNDr. Miroslav Červinka, CSc.
2 II. interní klinika Lékařské fakulty UK a FN Hradec Králové, přednosta prof. MUDr. Jaroslav Malý, CSc.
3 Radiologická klinika Lékařské fakulty UK a FN Hradec Králové, přednosta prof. MUDr. Pavel Eliáš, CSc.

Aim:
To analyze survival of patients after TIPS (transjugular intrahepatic portosystemic shunt).


Patient sample and methodology:
Between September 1992 and August 2010, TIPS was created in 848 patients of the University Hospital Hradec Kralove. These patients were divided into groups. Survival was analyzed using Kaplan-Meier survival curves. Differences between groups were evaluated using log-rank test.

Results:
Ten percent of patients do not survive one month after TIPS, 40% of patients survive 5 years and 20% of patients survive 10 years. There were statistically significant differences between groups divided according to Child-Pugh classification (A vs B p = 0.0053; B vs. C p < 0.0001), indication for surgery [prevention of bleeding recurrence differed from refractory ascites (p = 0.0001) and the indication to stop acute bleeding (p = 0.026)]; aetiology of the liver disease [patients with alcoholic cirrhosis differed from patients with Budd-Chiari syndrome (p < 0.0001) and from patients with chronic viral hepatitis (p = 0.024)].

Conclusion:
Survival of patients after TIPS is influenced by Child-Pugh score, indication and aetiology of the liver disease.

Keywords: transjugular intrahepatic portosystemic shunt; liver disease; Child-Pugh score; indication

Received: October 2, 2011; Published: December 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šembera Š, Jirkovský V, Fejfar T, Šafka V, Renc O, Raupach J, et al.. Survival of patients after TIPS in the University Hospital Hradec Kralove. Vnitr Lek. 2011;57(12):1038-1044.
Download citation

References

  1. Rösch J, Henafee WN, Snow H. Transjugular portal venography and radiologic portacaval shunt: an experimental study. Radiology 1969; 92: 1112-1114. Go to original source... Go to PubMed...
  2. Richter GM, Palmaz JC, Nöldge G et al. The transjugular intrahepatic portosystemic stent-shunt (TIPSS): a new nonoperatice, transjugular percutaneous procedure. Radiologe 1989; 29: 406-411. Go to PubMed...
  3. Fejfar T, Jirkovský V, Vaňásek T et al. Transjugulární intrahepatální portosystémová spojka - 15 let v Hradci Králové, retrospektivní analýza 694 případů. Čes a Slov Gastroent a Hepatol 2007; 61: 209-216.
  4. Krajina A, Lojík M. TIPS technique. In: Hůlek P, Krajina A et al. Current Practice of TIPS. Hradec Králové: Olga Štambergová 2001; 56-119.
  5. Moore KP, Wong F, Gines P et al. The Management of Ascites in Cirrhosis: Report on the consensus conference of the international Ascites Club. Hepatology 2003; 38: 258-266. Go to original source... Go to PubMed...
  6. Sanyal AJ, Genning C, Reddy KR et al. North American Study for the Treatment of Refractory Ascites Group. The North American Study for the Treatment of Refractory Ascites. Gastroenterology 2003; 124: 634-641. Go to original source... Go to PubMed...
  7. Rössle M, Grandt D. TIPS: an update. Best Pract Res Clin Gastroenterol 2004; 18: 99-123. Go to original source... Go to PubMed...
  8. Šafka V, Hůlek P, Krajina A et al. Budd-Chiari syndrome and TIPS - twelve years' experience. Čas Lék Čes 2005; 144 (Suppl 3): 38-42.
  9. Huonker M, Schumacher YO, Ochs A et al. Cardiac function and haemodynamics in alcoholic cirrhosis and effect of the transjugular intrahepatic portosystemic stent shunt. Gut 1999; 44: 743-748. Go to original source... Go to PubMed...
  10. Child III CG, Turcotte JG. Surgery and portal hypertension In: Child III CG (ed.). The Liver and Portal Hypertension. Philadelphia: Saunders 1964: 50.
  11. Pugh RN, Murray-Lyon IM, Dawson JL et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-649. Go to original source... Go to PubMed...
  12. Angermayr B, Cejna M, Karnel F et al. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut 2003; 52: 879-885. Go to original source... Go to PubMed...
  13. Tzeng WS, Wu RH, Lin CY et al. Prediction of Mortality after Emergent Transjugular Intrahepatic Portosystemic Shunt Placement: Use of APACHE II, Child-Pugh and MELD Scores in Asian Patients with Refractory Variceal Hemorrhage. Korean J Radiol 2009; 10: 481-489. Go to original source... Go to PubMed...
  14. Štefánková J, Fejfar T, Šafka V et al. Hepatic encephalopathy after TIPS - retrospective study. Vnitř Lék 2002; 48: 309-305.
  15. Jirkovsky V, Fejfar T, Safka T et al. Influence of the Secondary Deployment of Expanded Polytetrafluoroethylene-covered Stent Grafts on Maintenance of Transjugular Intrahepatic Portosystemic Shunt Patency. J Vasc Interv Radiol 2011; 22: 55-60. Go to original source... Go to PubMed...
  16. Zhuanq ZW, Tenq GJ, Jeffery RJ et al. Long-Term Results and Quality of Life in Patients Treated with Transjugular Intrahepatic Portosystemic Shunts. AJR Am J Roentgenol 2002; 179: 1597-1603. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.